Ivermectin for COVID-19: real-time meta analysis of 102 studies

0 0.5 1 1.5+ All studies 61% 102 142,307 Improvement, Studies, Patients Relative Risk Primary outcome 51% 102 142,350 Mortality 49% 51 122,827 Ventilation 29% 19 37,107 ICU admission 35% 14 28,039 Hospitalization 34% 29 44,784 Recovery 39% 38 12,889 Cases 81% 16 13,696 Viral clearance 41% 31 4,217 RCTs 53% 49 16,907 Peer-reviewed 60% 86 128,787 Prophylaxis 85% 17 19,764 Early 61% 39 58,804 Late 39

[muchonov]

イベルメクチンは「少なくともワクチンに比べて予防力・重症化防止力が非劣性とは言えない」て認識を持ってるけど、デルタ株以降でもこれぐりあの効果が出せるならちと話は変わってくるかもしれない